To match an exact phrase, use quotation marks around the search term. eg. "Parliamentary Estate". Use "OR" or "AND" as link words to form more complex queries.


Keep yourself up-to-date with the latest developments by exploring our subscription options to receive notifications direct to your inbox

Written Question
Parkinson’s Disease: Diagnosis
Monday 26th January 2026

Asked by: Helen Morgan (Liberal Democrat - North Shropshire)

Question to the Department of Health and Social Care:

To ask the Secretary of State for Health and Social Care, what steps he is taking to reduce the time taken for patients with Parkinson’s disease to receive a diagnosis.

Answered by Ashley Dalton - Parliamentary Under-Secretary (Department of Health and Social Care)

The Department recognises the importance of a timely diagnosis of Parkinson’s disease and the impact that early identification has on people’s long‑term outcomes. We remain committed to delivering the National Health Service constitutional standard for 92% of patients waiting no longer than 18 weeks from referral to treatment by March 2029. We are investing in additional capacity to deliver appointments to help bring lists and waiting times down. The Elective Reform Plan, published in January 2025, sets out the specific productivity and reform efforts needed to return to the constitutional standard.

National programmes like NHS England’s Getting It Right First Time (GIRFT) supports faster diagnosis by using clinically‑led, data‑driven reviews to identify delays and unwarranted variation in neurology services. GIRFT provides evidence‑based recommendations to streamline referral and outpatient pathways, improve data quality, and share best practice between trusts. This helps increase specialist capacity, reduce waiting times for assessment, and ensure more timely access to diagnosis for people with suspected Parkinson’s disease.

Additionally, by delivering the shifts outlined in the 10‑Year Health Plan, we can free up specialist capacity by increasing community‑based provision, reducing administrative burden through digital tools, and supporting earlier identification and management of neurological conditions like Parkinson’s. This will allow neurologists and geriatricians to focus on more complex cases and improve diagnostic timeliness.


Written Question
Respiratory Diseases: Diagnosis
Friday 23rd January 2026

Asked by: Helen Morgan (Liberal Democrat - North Shropshire)

Question to the Department of Health and Social Care:

To ask the Secretary of State for Health and Social Care, if his Department will make an assessment of the potential merits of commissioning neighbourhood level respiratory diagnostic hubs.

Answered by Stephen Kinnock - Minister of State (Department of Health and Social Care)

Respiratory diagnostic hubs have been piloted and developed in many parts of England and this learning will inform the development of more neighbourhood health services.

Community diagnostic centres (CDCs) are also supporting the shift to neighbourhood health, with 170 CDCs now being operational across England. All standard model CDCs are required to offer a range of diagnostic tests that support diagnosis of respiratory conditions, including spirometry and lung function tests.

CDCs offer local populations a wide range of diagnostic tests closer to home and greater choice on where and how they are undertaken, reducing the need for hospital visits and speeding up diagnosis, whilst also reducing pressure on hospitals.

We are continuing to invest in expanding diagnostic capacity in the National Health Service, including through increasing CDC capacity. As set out in the Elective reform Plan, we plan to build up to five more CDCs, as part of £600 million capital funding for diagnostics in 2025/26. We are also increasing the operating hours of existing sites so that more offer services 12 hours a day, seven days a week.


Written Question
NHS: Correspondence
Friday 23rd January 2026

Asked by: Helen Morgan (Liberal Democrat - North Shropshire)

Question to the Department of Health and Social Care:

To ask the Secretary of State for Health and Social Care, what steps he is taking to ensure the timely delivery of NHS mail to patients.

Answered by Karin Smyth - Minister of State (Department of Health and Social Care)

The Department of Health and Social Care has indicated that it will not be possible to answer this question within the usual time period. An answer is being prepared and will be provided as soon as it is available.


Written Question
Respiratory Diseases
Thursday 22nd January 2026

Asked by: Helen Morgan (Liberal Democrat - North Shropshire)

Question to the Department of Health and Social Care:

To ask the Secretary of State for Health and Social Care, if he will outline the criteria used to decide which conditions should receive a modern service framework; and whether respiratory health meets these criteria.

Answered by Karin Smyth - Minister of State (Department of Health and Social Care)

I refer the hon. Member to the answer I gave to the hon. Member for Lewes on 27 October 2025 to Question 82544.


Written Question
NHS: Drugs
Thursday 22nd January 2026

Asked by: Helen Morgan (Liberal Democrat - North Shropshire)

Question to the Department of Health and Social Care:

To ask the Secretary of State for Health and Social Care, whether he has made an assessment of the potential impact of NHS spending on pharmaceutical products on NHS service provision in the context of the UK-US trade deal.

Answered by Zubir Ahmed - Parliamentary Under-Secretary (Department of Health and Social Care)

By increasing the standard National Institute for Health and Care Excellence (NICE) cost-effectiveness threshold, we are increasing the value that we place on innovations that deliver improvements to patient health. Alongside the changes that we announced in the Life Sciences Sector Plan, this will increase both the speed and breadth of patient access to innovative medicines and encourage growth in United Kingdom-based clinical trials.

Costs will start smaller but will increase over time as the NICE approves more life improving and lifesaving medicines. Total costs over the Spending Review period are expected to be approximately £1 billion. But the final costs will depend on which medicines NICE decides to approve and the actual uptake of these.

This deal is a vital investment that builds on the strength of our National Health Service and world leading life sciences sector to increase access to life-changing medicines without taking essential funding from our frontline NHS services. We will always prioritise the needs of NHS patients and at the Spending Review we delivered a record real terms increase for day-to-day spending for the NHS in England up to April 2029.

This deal will be funded by allocations made at the Spending Review, where front line services will remain protected through the record funding secured. Future year funding will be settled at the next Spending Review.


Written Question
Respiratory Diseases: Diagnosis
Tuesday 20th January 2026

Asked by: Helen Morgan (Liberal Democrat - North Shropshire)

Question to the Department of Health and Social Care:

To ask the Secretary of State for Health and Social Care, if his Department will take steps to help ensure that health boards and trusts collect and publish data on the provision of respiratory diagnostics.

Answered by Karin Smyth - Minister of State (Department of Health and Social Care)

I refer the Hon. Member to the answer I gave to the Hon. Member for Chelmsford on 27 October 2025 to Question 83430.


Written Question
Respiratory Diseases
Tuesday 20th January 2026

Asked by: Helen Morgan (Liberal Democrat - North Shropshire)

Question to the Department of Health and Social Care:

To ask the Secretary of State for Health and Social Care, what steps he is taking to help reduce the potential impact of chronic respiratory conditions on the NHS this winter.

Answered by Karin Smyth - Minister of State (Department of Health and Social Care)

NHS England, working with the Department, the UK Health Security Agency, and other partners, is taking action to reduce the impact of respiratory conditions on the National Health Service this winter. This includes robust, consistent Infection Prevention and Control measures, and a campaign to encourage eligible people to get their winter vaccinations. Further details of the actions being taken to reduce demand on acute services during winter are available at the following link:

https://www.england.nhs.uk/long-read/urgent-and-emergency-care-plan-2025-26/


Written Question
Respiratory Diseases: Diagnosis
Monday 19th January 2026

Asked by: Helen Morgan (Liberal Democrat - North Shropshire)

Question to the Department of Health and Social Care:

To ask the Secretary of State for Health and Social Care, what steps he is taking to help (a) increase capacity for and (b) reduce inequalities in access to respiratory diagnosis.

Answered by Ashley Dalton - Parliamentary Under-Secretary (Department of Health and Social Care)

Community diagnostic centres (CDCs) are increasing capacity and access to respiratory diagnostic tests such as spirometry and fractional exhaled nitric oxide, and will continue to do so as more sites come online. For example, the first five months of 2025/26 saw an increase in CDC spirometry testing of approximately 2,000 tests per month more than in the previous year.

In addition, 101 CDCs across the country now offer out-of-hours services 12 hours a day, seven days a week, meaning patients across the country can access vital diagnostic tests around busy working lives.


Written Question
NHS: Staff
Wednesday 14th January 2026

Asked by: Helen Morgan (Liberal Democrat - North Shropshire)

Question to the Department of Health and Social Care:

To ask the Secretary of State for Health and Social Care, what steps he is taking to incorporate the National Audit Office recommendations regarding the 2023 Long Term Workforce Plan into the development of the 10 Year Workforce Plan.

Answered by Karin Smyth - Minister of State (Department of Health and Social Care)

The 10 Year Workforce Plan will ensure the National Health Service has the right people in the right places, with the right skills to care for patients, when they need it.

To address the National Audit Office’s recommendations regarding the 2023 Long Term Workforce Plan, updated workforce modelling and its underlying assumptions will be set out in and alongside the new plan when published in spring 2026. It will be supported by external independent scrutiny.

We are committed to engagement with external stakeholders. On the 26 September 2025 we launched a formal call for evidence, which provided stakeholders the opportunity to contribute directly to the plan’s development. This closed on 7 November 2025. The submissions to our call for evidence are being analysed to inform the development of the plan.


Written Question
NHS: Staff
Wednesday 14th January 2026

Asked by: Helen Morgan (Liberal Democrat - North Shropshire)

Question to the Department of Health and Social Care:

To ask the Secretary of State for Health and Social Care, what assessment his Department has made of the National Audit Office recommendations in its analysis of the 2023 Long Term Workforce Plan (a) in general and (b) specifically the recommendation that assumptions should be generated in transparent and systematic consultation with external stakeholders.

Answered by Karin Smyth - Minister of State (Department of Health and Social Care)

The 10 Year Workforce Plan will ensure the National Health Service has the right people in the right places, with the right skills to care for patients, when they need it.

To address the National Audit Office’s recommendations regarding the 2023 Long Term Workforce Plan, updated workforce modelling and its underlying assumptions will be set out in and alongside the new plan when published in spring 2026. It will be supported by external independent scrutiny.

We are committed to engagement with external stakeholders. On the 26 September 2025 we launched a formal call for evidence, which provided stakeholders the opportunity to contribute directly to the plan’s development. This closed on 7 November 2025. The submissions to our call for evidence are being analysed to inform the development of the plan.